Abstract:Exquisite binding specificity is essential for many protein functions but is difficult to engineer. Many biotechnological or biomedical applications require the discrimination of very similar ligands, which poses the challenge of designing protein sequences with highly specific binding profiles. Experimental methods for generating specific binders rely on in vitro selection, which is limited in terms of library size and control over specificity profiles. Additional control was recently demonstrated through high-throughput sequencing and downstream computational analysis. Here we follow such an approach to demonstrate the design of specific antibodies beyond those probed experimentally. We do so in a context where very similar epitopes need to be discriminated, and where these epitopes cannot be experimentally dissociated from other epitopes present in the selection. Our approach involves the identification of different binding modes, each associated with a particular ligand against which the antibodies are either selected or not. Using data from phage display experiments, we show that the model successfully disentangles these modes, even when they are associated with chemically very similar ligands. Additionally, we demonstrate and validate experimentally the computational design of antibodies with customized specificity profiles, either with specific high affinity for a particular target ligand, or with cross-specificity for multiple target ligands. Overall, our results showcase the potential of leveraging a biophysical model learned from selections against multiple ligands to design proteins with tailored specificity, with applications to protein engineering extending beyond the design of antibodies. A great challenge in protein science is to relate sequences to physical properties, both to predict physical properties from sequences, and to design sequences with desired phenotypes. A promising solution lies in integrating large-scale selection experiments, high-throughput sequencing, and machine learning techniques. However, existing models often focus solely on the property under selection ("fitness"), lacking interpretability. This limits our fundamental understanding of proteins and our ability to engineer them for desired properties, especially those not directly selectable in experiments. Previous studies have shown that incorporating biophysical constraints into models can offer quantitative insights, particularly in transcription factors Here, we demonstrate that when coupled with extensive experiments, such modeling can not only predict physical features but also design new proteins with specific properties. Our demonstration involves a problem of primary biotechnological and biomedical interest: the design of antibodies with defined specificity profiles. We focus on one of the most challenging tasks in the field, designing antibodies capable of discriminating between structurally and chemically similar ligands. This approach has applications for creating antibodies with both specific and cross-specific binding properties and for mitigating experimental artifacts and biases in selection experiments. The combination of biophysics-informed modeling and extensive selection experiments holds broad applicability beyond antibodies, offering a powerful toolset for designing proteins with desired physical properties.

Antibodies from Combinatorial Libraries Use Functional Receptor Pleiotropism to Regulate Cell Fates

i-shaped antibody engineering enables conformational tuning of biotherapeutic receptor agonists

Antibody agonists trigger immune receptor signaling through local exclusion of receptor-type protein tyrosine phosphatases

Immunity as biophysics at the surface of a T cell

Aptamers Against Cell Surface Receptors: Selection, Modification and Application

Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody libraries

Lectins and antibodies as tools for studying cellular interactions

Living in LALA land? Forty years of attenuating Fc effector functions

Reducing affinity as a strategy to boost immunomodulatory antibody agonism

Discovery of antibodies targeting multipass transmembrane proteins using a suspension cell-based evolutionary approach

Reversible Chemical Modification of Antibody Effector Function Mitigates Unwanted Systemic Immune Activation

Display of Polyvalent Hybrid Antibodies on the Cell Surface for Enhanced Cell Recognition

Differential Roles of Kinetic On- and Off-Rates in T-Cell Receptor Signal Integration Revealed with a Modified Fab’-DNA Ligand

Recombinant human antibodies: linkage of an Fab fragment from a combinatorial library to an Fc fragment for expression in mammalian cell culture

Inference and design of antibody specificity: From experiments to models and back

The Dawn of a New Era: Targeting the "Undruggables" with Antibody-Based Therapeutics.

Design, Construction, and Validation of a Yeast-Displayed Chemically Expanded Antibody Library

A platform for the early selection of non-competitive antibody-fragments from yeast surface display libraries

Perioperative hypercoagulability in uremic patients: a viscoelastic study.

Function-based High-Throughput Screening for Antibody Antagonists and Agonists Against G Protein-Coupled Receptors

Abstract 89: Comprehensive cell based bioassay approaches for characterization, and clinical development of therapeutic agonistic antibodies for cancer immunotherapy and autoimmune diseases